Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B

NCT03349008 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis b
Liver Inflammation

Interventions

DRUG: Entecavir
DRUG: Magnesium Isoglycyrrhizinate
DRUG: Diammonium Glycyrrhizinate
DRUG: Magnesium Isoglycyrrhizinate Placebo
DRUG: Diammonium Glycyrrhizinate Placebo

Sponsor

Cttq